Thorne is a science-driven wellness company driven by data and rooted in scientific rigor to deliver personalized approaches to health and wellness. Thorne’s personalized supplement and testing portfolio leverages clinical science, biometric testing, and multi-omics data to create highly efficacious nutritional supplements for consumers, health professionals, and corporations. Thorne's manufacturing facility is based in Summerville, South Carolina, and is the only supplement manufacturer that collaborates with Mayo Clinic on health and wellness research and content. Thorne is trusted by more than five million customers, 47,000+ health-care professionals, thousands of professional athletes, more than 100 professional sports teams, and multiple U.S. National Teams.

Integrated into Nestle Health Science after its acquisition of The Bountiful Company in August 2021. Responsible for all Innovation/Product Development of our global VMHS (Dietary Supplement) Brands (Nature’s Bounty, Pure Encapsulations, Solgar, Osteo Bi-Flex, Puritan’s Pride, NUUN, Private Brand) and the Solid Dose, Gummy and Packaging R&D functional teams. New Products launched under my stewardship since Nestle’s acquisition represent $200MM+ of our $1.5B+ annual VMHS revenues. Recent Innovation launches since our acquisition in late 2021 include Sleep3 Time Release Melatonin Gummies, Metabolism Booster and Hair Growth capsules- market leading Innovations that are differentiated by science, consumer product experience and technical storytelling. Advanced 2025 Packaging Sustainability goals with Innovations and Technology solutions developed towards achieving 100% Recyclability/Reuse and 33% reduction in virgin plastic. Responsible for integration of all VMHS R&D post-acquisition (People, Systems, Ways of Working) into Nestle Global R&D including the approval and installation of a Gummy R&D lab/pilot plant of $4MM+.

Head of New Product Development and R&D Operations (Project and Portfolio Management, Centralized Data Operations) for leading $2B+ private equity owned health and wellness company in the dietary supplement and nutritional industry. Responsible for product and project design, development, delivery and pipeline build for major health and wellness Brands such as NATURE’S BOUNTY, SUNDOWN NATURALS, SOLGAR, PURE PROTEIN, OSTEO BI-FLEX, BALANCE BAR, MET-Rx and BODY FORTRESS. Executive leader responsible for increasing valuation over 200% during our ownership period under KKR, increasing our NPD freshness from 6% to 15% (revenues from New Products), establishing major new Platforms in Sleep (Sleep 3 Tri-layer), Immunity (Immune 24 hour), Pure Protein and Body Fortress RTD’s and bars, Solgar Curcumin, Nature’s Bounty Advanced line (D+Mag, Aquacelle CoQ10, Hair/Skin/Nails), CoolMelt Stress Relief Tablets and Jelly Bean Vitamin line (new delivery forms). In 2016-2018 timeframe, built PD Team from a team of 2 to a high performing, market-leading R&D Team of 25+. Co-leader with US President in developing and building our New Products 3-year Pipeline as VMHS Franchise Lead from 2019-2022 ($250-350MM annual Pipeline value). R&D Lead on all Top-to-Top Customer Innovation engagements with Walmart, Costco, CVS, Key Accounts. Active team member in business development deals including company sale in 2017(KKR) and 2021(Nestle).Managed R&D budget of $12MM and multiple fee-for-service external partnerships.

The Nature's Bounty Company is a private-equity owned (KKR), $2B+ global consumer health and wellness company. I am currently in charge of our Product Development/R&D team- Product Development, Packaging Design & Development, Consumer Science, R&D Operations, Analytical Science & Stability for our VMHS (vitamins, minerals, herbal supplements) Brands, including Nature's Bounty, Optimal Solutions, Sundown Naturals, Osteo Bi-Flex, Ester-C and our SAN (Sports & Active Nutrition) Brands including Pure Protein, Met-Rx, Body Fortress, Best Bar Ever and Balance Bar, reporting to the President, CPG North America and the Chief Scientific Officer during my time here. I am also the SAN Franchise Leader responsible for 3-yr Innovation Pipeline Build & Delivery . Earlier in my tenure, I was responsible as interim head for the R&D Operations/PM group, which is accountable for project and portfolio management and our Stage-Gate NPD processes.

In my current position, I am responsible for new business development and product commercialization, as a member of the senior Management Team, reporting to the CEO. Chromocell®, founded in 2002, is a life sciences company which improves consumer products and patient lives through breakthrough science and technologies. We are focused on the discovery and development of flavors and nutritional ingredients, and therapeutics through our pioneering Chromovert® technology. Chromovert® enables us to use naturally occurring cells and receptors in high performance discovery platforms.

Broad-based consumer goods consulting, including roles as Vice President, Business Development at Five Star Professional and Director, Technology & Innovation at Sensient Natural Ingredients.

Head of R&D for the leading immune support dietary supplement Brand in the cough cold category. Leadership of R&D group functions (Science & Clinical Research, Regulatory, Product Development, Front End of Innovation, Tech Transfer) leveraging an external network of strategic suppliers and partnerships. Co-lead of consumer-centric Innovation Pipeline Team. Chairman of CRN Government (State) Relations Subcommittee and the Airborne Science Council. Reported to CEO and managed budget of $1.6MM. • Increased net sales 37%, improved gross margin by 20.4 pts. and returned Airborne to profitability with a 220% increase in EBITDA over the ownership period as a member of the Management Team.• Rapidly expanded the new product pipeline with credible, science-based offerings, increasing pipeline value to $100 MM. Launched AIRBORNE Chewables with year 1 sales of $17MM, and AIRBORNE Plus Energy and Hot Honey Lemon drink mix with estimated year 1 sales of $15MM.• Conducted primary evidence-based testing of current Airborne products (biomarker and pilot efficacy clinical trials) validating Airborne’s mechanism of action in providing immune support.• Sold business to Schiff Nutrition generating a 500% ROI for our private equity owners.

As part of my give-back to Babson, I invest time in coaching and mentoring current students in leadership and teamwork skills.

Responsible for Global Innovation group with 5 direct reports.in Formulation and Packaging Development. Leadership of teams developing and commercializing Welch's ESSENTIALS cocktail juices, HEALTHY START refrigerated juices, Welch's Naturals (Spreads) and launch of the Innovation room and Front End of Innovation process. Member of the Innovation Leadership Team.

Leadership of R&D group coordinating new product development, licensing and acquisition support for the HEALTH SIMPLE (Diabetes & Obesity) Brand and R&D System group accountable for R&D Knowledge & Talent Management, Innovation and IP functions. Managed 5 directs/5 indirects and external partner network. Member of Global Strategic Business Team with P&L, Business and Strategic Plan accountability.• Transferred technology and started up VIACTIV/BENECOL chew supplements at manufacturing site saving $4MM, reducing COGS 20%, improving taste claims and ensuring DSHEA compliance.• Pioneered clinically relevant nutritional products addressing unmet needs in the Diabetes and Obesity categories and generating $100MM+ new product pipeline value.• Identified technology targets and conducted due diligence on 10+ licensing, acquisition and divestiture candidates enabling delivery of McNeil’s Business and Strategic Plan.Director, Product Development & Technical Services, McNeil Nutritionals (2002-2008)Leadership of global VIACTIV, LACTAID, BENECOL R&D teams supporting all global Innovation, Demand Generation and Supply Chain Delivery on the Global R&D Leadership Team. Co-leader of Brand Teams with P&L, Business and Strategic Plan accountability. Managed 5 directs/12 indirects/$3.5MM budget as PD Leader. Established Weight Management technology platform with clinical supplies support. • Designed, developed and commercialized 16+ major Innovation Pipeline products for the SPLENDA, VIACTIV, LACTAID and BENECOL Franchises with estimated revenues of $200MM+.Manager, Commercialization, McNeil Consumer Healthcare (1998-2000)Formulation, Product, Clinical Supplies and Process Development of broad range of functional foods for pioneering BENECOL venture (cholesterol lowering functional foods). Management of external consultants and 1 direct report to execute formulation, process and analytical tasks.

Process development project leader on FLEISCHMANN’s bioactive-enriched spreads, PLANTERS mixed nuts and low-fat extruded snack NPD, productivity and manufacturing infrastructure programs with 1 direct report.

Program leader on SKIPPY Reduced Fat Platform and Dressings process development. Project leader with 5 indirect reports. NPD, reformulation and cost improvement of existing products, tech service support and troubleshooting to peanut butter/dressings Operations. Pilot/Plant scale-up of HELLMANN’s salad dressings.

Conducted product and process development of new products, line extensions, cost improvement of shelf-stable, refrigerated and frozen food products, meal components, sauces and salad dressings.